Cogniprin Memory Drug Class Action Investigation

Investigating a class action lawsuit on behalf of consumers of FlexiPrin and Cogniprin. Both drugs were falsely advertised as having memory-improvement functions. The Maine Attorney General recently opened an investigation into the fraudulent sale of these drugs, alleging their manufacturers misled consumers about the health benefits of the drugs, how much they costed, and how consumers could get their money back. If you bought FlexiPrin or Cogniprin, please contact us.

Disclaimer